ImportantUpdates
Torrent Pharma submitted its FY25-26 BRSR, showcasing strong ESG performance and improved resource efficiency.
Torrent Pharmaceuticals LimitedTORNTPHARM · Filed with the exchange
The company incurred over ` 48 crore in fines from NPPA and GST authorities for various issues.
Operational advancements and local sourcing initiatives continue.
No comments yet. Be the first.